Suppression of the fibrotic encapsulation of silicone implants by inhibiting the mechanical activation of pro-fibrotic TGF-β

Nina Noskovicova,Ronen Schuster,Sander van Putten,Maya Ezzo,Anne Koehler,Stellar Boo,Nuno M. Coelho,David Griggs,Peter Ruminski,Christopher A. McCulloch,Boris Hinz
DOI: https://doi.org/10.1038/s41551-021-00722-z
IF: 28.1
2021-05-24
Nature Biomedical Engineering
Abstract:The fibrotic encapsulation of implants involves the mechanical activation of myofibroblasts and of pro-fibrotic transforming growth factor beta 1 (TGF-β1). Here, we show that both softening of the implant surfaces and inhibition of the activation of TGF-β1 reduce the fibrotic encapsulation of subcutaneous silicone implants in mice. Conventionally stiff silicones (elastic modulus, ~2 MPa) coated with a soft silicone layer (elastic modulus, ~2 kPa) reduced collagen deposition as well as myofibroblast activation without affecting the numbers of macrophages and their polarization states. Instead, fibroblasts around stiff implants exhibited enhanced intracellular stress, increased the recruitment of α<sub>v</sub> and β<sub>1</sub> integrins, and activated TGF-β1 signalling. In vitro, the recruitment of α<sub>v</sub> integrin to focal adhesions and the activation of β<sub>1</sub> integrin and of TGF-β were higher in myofibroblasts grown on latency-associated peptide (LAP)-coated stiff silicones than on soft silicones. Antagonizing α<sub>v</sub> integrin binding to LAP through the small-molecule inhibitor CWHM-12 suppressed active TGF-β signalling, myofibroblast activation and the fibrotic encapsulation of stiff subcutaneous implants in mice.
engineering, biomedical
What problem does this paper attempt to address?